Surgical Oncologist Alexander Kutikov, MD, Joins Fox Chase's Department of Surgery

August 12, 2010

PHILADELPHIA (August 12, 2010) – Surgical Oncologist Alexander Kutikov, MD, FACS - Attending Surgeon, Urologic Oncology , has joined Fox Chase Cancer Center’s department of surgery after completing a Society of Urologic Oncology Fellowship at the Center.  He specializes in the treatment of patients with adrenal, kidney, ureteral, bladder, prostate, urethral, testicular, and retroperitoneal cancers. 

Kutikov has extensive training in minimally invasive surgical techniques for the treatment of urologic cancers, including nerve-sparing robotic surgery for men with prostate cancer as well as organ-sparing surgery for patients with kidney cancer.  He also specializes in treating advanced cancers, such as kidney cancer with tumor thrombus, bladder cancer requiring neobladder reconstruction, and surgery after chemotherapy for testicular cancer.

“Fox Chase is a place like no other,” Kutikov says.  “The mission is not only to deliver world-class care, but to do so in the most compassionate way possible.”

Kutikov’s training in both traditional open surgery and minimally-invasive surgery allows him to offer a wide range of treatment options to his patients.  Although he is a surgeon, Kutikov acknowledges that surgery is not the right choice for everyone. 

“I work closely with other members of the Fox Chase multidisciplinary team to make certain that my patients are aware of all their choices, regardless of whether these treatments take place inside or outside of the operating room,” he notes.

Kutikov has authored more than 25 original manuscripts in peer-reviewed journals, including the Journal of Clinical Oncology.  He has published chapters in leading urologic textbooks, including the definitive chapter on adrenal disorders in “Campbell-Walsh Urology.”  Kutikov’s work also includes numerous abstracts, presentations, and a urological device patent.  He is an associate fellow of the American College of Surgeons and serves as the urology representative to the group’s Urology Advisory Council.  He also is the co-founder of, the leading internet portal for urologic training.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase